NCT02272764View on ClinicalTrials.gov

A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Pharmacokinetics
Interventions
DRUG

Itraconazole

Administered orally in a crossover design

DRUG

ALKS 5461

Administered sublingually in a crossover design

Trial Locations (1)

66212

Alkermes Investigational Site, Overland Park

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY

NCT02272764 - A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers | Biotech Hunter | Biotech Hunter